Concepts (202)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Staphylococcal Infections | 4 | 2018 | 1099 | 1.46 | Why? |
| Hypotension | 2 | 2019 | 392 | 1.14 | Why? |
| Methicillin-Resistant Staphylococcus aureus | 2 | 2018 | 711 | 0.90 | Why? |
| Retraction of Publication as Topic | 1 | 2021 | 77 | 0.86 | Why? |
| Penicillins | 2 | 2018 | 132 | 0.80 | Why? |
| Deprescriptions | 2 | 2020 | 294 | 0.78 | Why? |
| Bacteremia | 4 | 2018 | 1372 | 0.77 | Why? |
| Cloxacillin | 1 | 2018 | 14 | 0.76 | Why? |
| Cefazolin | 1 | 2018 | 31 | 0.73 | Why? |
| Latent Autoimmune Diabetes in Adults | 1 | 2017 | 5 | 0.73 | Why? |
| Gliclazide | 1 | 2017 | 13 | 0.70 | Why? |
| Daptomycin | 1 | 2018 | 64 | 0.70 | Why? |
| Staphylococcus aureus | 3 | 2018 | 844 | 0.67 | Why? |
| Unnecessary Procedures | 1 | 2017 | 175 | 0.57 | Why? |
| Hypnotics and Sedatives | 2 | 2018 | 624 | 0.57 | Why? |
| Hypoglycemia | 1 | 2017 | 406 | 0.48 | Why? |
| Laboratories, Hospital | 1 | 2017 | 489 | 0.47 | Why? |
| Publishing | 1 | 2021 | 990 | 0.44 | Why? |
| Bayes Theorem | 1 | 2021 | 3237 | 0.44 | Why? |
| Mindfulness | 1 | 2017 | 437 | 0.43 | Why? |
| Metformin | 1 | 2017 | 640 | 0.41 | Why? |
| Diabetic Ketoacidosis | 1 | 2017 | 622 | 0.40 | Why? |
| Drug Prescriptions | 1 | 2017 | 1062 | 0.36 | Why? |
| Hydroxychloroquine | 6 | 2021 | 12447 | 0.34 | Why? |
| Hand Hygiene | 1 | 2018 | 1493 | 0.33 | Why? |
| Blood Pressure | 1 | 2018 | 2198 | 0.32 | Why? |
| Quebec | 5 | 2020 | 498 | 0.32 | Why? |
| Polypharmacy | 3 | 2020 | 347 | 0.32 | Why? |
| Anti-Bacterial Agents | 5 | 2018 | 10083 | 0.31 | Why? |
| Hypertension | 2 | 2018 | 8895 | 0.30 | Why? |
| Antihypertensive Agents | 1 | 2018 | 1962 | 0.30 | Why? |
| Post-Exposure Prophylaxis | 2 | 2020 | 472 | 0.30 | Why? |
| Vancomycin | 2 | 2018 | 328 | 0.29 | Why? |
| Diabetes Complications | 1 | 2017 | 2358 | 0.28 | Why? |
| Guideline Adherence | 1 | 2018 | 2309 | 0.28 | Why? |
| Saliva | 1 | 2021 | 4679 | 0.27 | Why? |
| Inpatients | 2 | 2018 | 5161 | 0.27 | Why? |
| Canada | 9 | 2021 | 6018 | 0.27 | Why? |
| Adrenal Cortex Hormones | 1 | 2021 | 6537 | 0.26 | Why? |
| Adenosine Monophosphate | 1 | 2021 | 5652 | 0.25 | Why? |
| Alanine | 1 | 2021 | 5687 | 0.25 | Why? |
| Interleukin-6 | 1 | 2021 | 7522 | 0.24 | Why? |
| Antibodies, Monoclonal, Humanized | 2 | 2021 | 9335 | 0.23 | Why? |
| Cross Infection | 3 | 2018 | 8675 | 0.22 | Why? |
| Kidney Failure, Chronic | 1 | 2017 | 3222 | 0.21 | Why? |
| Potentially Inappropriate Medication List | 1 | 2020 | 55 | 0.21 | Why? |
| Clinical Pharmacy Information Systems | 1 | 2018 | 2 | 0.19 | Why? |
| Penicillin G | 1 | 2018 | 14 | 0.19 | Why? |
| Effect Modifier, Epidemiologic | 1 | 2018 | 39 | 0.18 | Why? |
| Medical Record Linkage | 1 | 2018 | 58 | 0.18 | Why? |
| Medication Reconciliation | 1 | 2018 | 41 | 0.18 | Why? |
| Mass Screening | 1 | 2018 | 8005 | 0.18 | Why? |
| Skin Diseases, Bacterial | 1 | 2018 | 105 | 0.17 | Why? |
| Soft Tissue Infections | 1 | 2018 | 116 | 0.16 | Why? |
| Probability | 1 | 2021 | 923 | 0.16 | Why? |
| Angiography | 1 | 2018 | 301 | 0.16 | Why? |
| Cardiovascular Diseases | 1 | 2021 | 11497 | 0.16 | Why? |
| Medical Overuse | 1 | 2018 | 146 | 0.15 | Why? |
| Double-Blind Method | 4 | 2020 | 5988 | 0.15 | Why? |
| Budesonide | 1 | 2017 | 192 | 0.15 | Why? |
| Diabetes Mellitus | 1 | 2017 | 8207 | 0.14 | Why? |
| Adrenal Insufficiency | 1 | 2017 | 190 | 0.14 | Why? |
| Multicenter Studies as Topic | 2 | 2020 | 2437 | 0.14 | Why? |
| Myocardial Ischemia | 1 | 2021 | 781 | 0.14 | Why? |
| Inappropriate Prescribing | 1 | 2018 | 284 | 0.14 | Why? |
| Cost Savings | 1 | 2017 | 296 | 0.14 | Why? |
| Disease Transmission, Infectious | 1 | 2018 | 9044 | 0.14 | Why? |
| Blood Pressure Determination | 1 | 2018 | 450 | 0.14 | Why? |
| Humans | 35 | 2021 | 930598 | 0.14 | Why? |
| Drug Therapy, Combination | 2 | 2018 | 7268 | 0.13 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.13 | Why? |
| Sentinel Surveillance | 1 | 2020 | 1093 | 0.12 | Why? |
| Hospitalization | 4 | 2021 | 54280 | 0.12 | Why? |
| Streptococcus pneumoniae | 1 | 2018 | 827 | 0.12 | Why? |
| Multimorbidity | 1 | 2017 | 703 | 0.12 | Why? |
| Pre-Exposure Prophylaxis | 1 | 2021 | 1138 | 0.12 | Why? |
| Catheterization, Central Venous | 1 | 2017 | 458 | 0.11 | Why? |
| Community Pharmacy Services | 1 | 2018 | 426 | 0.11 | Why? |
| Pneumococcal Infections | 1 | 2018 | 562 | 0.11 | Why? |
| Physical Therapy Modalities | 1 | 2020 | 1090 | 0.11 | Why? |
| Withholding Treatment | 1 | 2017 | 798 | 0.11 | Why? |
| Drug Administration Schedule | 1 | 2018 | 2324 | 0.11 | Why? |
| Weight Loss | 1 | 2017 | 826 | 0.11 | Why? |
| Pulmonary Artery | 1 | 2018 | 803 | 0.11 | Why? |
| Antimicrobial Stewardship | 1 | 2018 | 931 | 0.10 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2020 | 10649 | 0.10 | Why? |
| Pharmacy Service, Hospital | 1 | 2018 | 645 | 0.10 | Why? |
| Pulmonary Embolism | 2 | 2018 | 4775 | 0.09 | Why? |
| Proportional Hazards Models | 2 | 2018 | 6543 | 0.09 | Why? |
| Infection Control | 1 | 2018 | 23131 | 0.09 | Why? |
| Hospitals, Teaching | 1 | 2017 | 1609 | 0.09 | Why? |
| Heart Failure | 2 | 2021 | 6638 | 0.09 | Why? |
| Self Report | 1 | 2020 | 3802 | 0.09 | Why? |
| Respiratory Tract Infections | 2 | 2018 | 6817 | 0.08 | Why? |
| Outpatients | 1 | 2020 | 3417 | 0.08 | Why? |
| Frail Elderly | 1 | 2017 | 1427 | 0.08 | Why? |
| Nutritional Status | 1 | 2017 | 1403 | 0.08 | Why? |
| Odds Ratio | 1 | 2018 | 5861 | 0.08 | Why? |
| Software | 1 | 2018 | 2501 | 0.08 | Why? |
| Respiration, Artificial | 3 | 2021 | 22116 | 0.07 | Why? |
| Frailty | 1 | 2017 | 1432 | 0.07 | Why? |
| Mortality | 2 | 2021 | 7132 | 0.07 | Why? |
| Treatment Outcome | 4 | 2020 | 51732 | 0.07 | Why? |
| Hypoglycemic Agents | 1 | 2017 | 2165 | 0.07 | Why? |
| Pilot Projects | 3 | 2020 | 5182 | 0.07 | Why? |
| Mobile Applications | 1 | 2019 | 3032 | 0.06 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 5277 | 0.06 | Why? |
| Patient Discharge | 1 | 2019 | 5696 | 0.06 | Why? |
| Male | 15 | 2021 | 367725 | 0.06 | Why? |
| Predictive Value of Tests | 1 | 2018 | 9537 | 0.06 | Why? |
| Ritonavir | 1 | 2017 | 4212 | 0.06 | Why? |
| Risk Factors | 4 | 2020 | 71621 | 0.06 | Why? |
| Myocardial Infarction | 1 | 2018 | 3361 | 0.06 | Why? |
| Retrospective Studies | 6 | 2020 | 105322 | 0.06 | Why? |
| Female | 13 | 2021 | 380317 | 0.06 | Why? |
| Machine Learning | 1 | 2018 | 4395 | 0.06 | Why? |
| Aged | 10 | 2021 | 215776 | 0.06 | Why? |
| Time Factors | 3 | 2020 | 31397 | 0.05 | Why? |
| Aging | 1 | 2017 | 3581 | 0.05 | Why? |
| Equivalence Trials as Topic | 1 | 2020 | 242 | 0.05 | Why? |
| Sensitivity and Specificity | 1 | 2021 | 22971 | 0.05 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.05 | Why? |
| Coronavirus Infections | 7 | 2020 | 253789 | 0.05 | Why? |
| Students | 1 | 2018 | 5255 | 0.05 | Why? |
| Practice Patterns, Physicians' | 1 | 2018 | 4927 | 0.05 | Why? |
| Formularies as Topic | 1 | 2018 | 13 | 0.05 | Why? |
| Penicillin Resistance | 1 | 2018 | 15 | 0.05 | Why? |
| Health Behavior | 1 | 2017 | 4449 | 0.05 | Why? |
| Methicillin Resistance | 1 | 2018 | 77 | 0.05 | Why? |
| Asthma | 1 | 2017 | 4383 | 0.05 | Why? |
| Pamphlets | 1 | 2018 | 27 | 0.05 | Why? |
| Medication Errors | 1 | 2018 | 107 | 0.04 | Why? |
| Comorbidity | 2 | 2021 | 34796 | 0.04 | Why? |
| Critical Care | 1 | 2021 | 14081 | 0.04 | Why? |
| Anticoagulants | 1 | 2018 | 9563 | 0.04 | Why? |
| Influenza, Human | 1 | 2021 | 10779 | 0.04 | Why? |
| Inhalation Exposure | 1 | 2020 | 405 | 0.04 | Why? |
| Pandemics | 8 | 2021 | 389249 | 0.04 | Why? |
| Influenza B virus | 1 | 2021 | 815 | 0.04 | Why? |
| Down-Regulation | 1 | 2021 | 1416 | 0.04 | Why? |
| Ultrasonography, Doppler | 1 | 2018 | 406 | 0.04 | Why? |
| Biomarkers | 1 | 2018 | 23361 | 0.04 | Why? |
| Stroke | 1 | 2018 | 8839 | 0.03 | Why? |
| Treatment Failure | 1 | 2020 | 2106 | 0.03 | Why? |
| Aged, 80 and over | 3 | 2021 | 88759 | 0.03 | Why? |
| HIV Protease Inhibitors | 1 | 2017 | 434 | 0.03 | Why? |
| Middle Aged | 7 | 2021 | 270681 | 0.03 | Why? |
| Government Regulation | 1 | 2020 | 842 | 0.03 | Why? |
| Natural Language Processing | 1 | 2017 | 436 | 0.03 | Why? |
| Practice Guidelines as Topic | 1 | 2017 | 15421 | 0.03 | Why? |
| Bronchodilator Agents | 1 | 2017 | 444 | 0.03 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.03 | Why? |
| HIV Infections | 1 | 2017 | 11620 | 0.03 | Why? |
| Telephone | 1 | 2020 | 1705 | 0.03 | Why? |
| Lung | 1 | 2020 | 31049 | 0.03 | Why? |
| False Negative Reactions | 1 | 2018 | 1785 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2018 | 25144 | 0.03 | Why? |
| Administration, Inhalation | 1 | 2017 | 1647 | 0.03 | Why? |
| Follow-Up Studies | 2 | 2020 | 17020 | 0.03 | Why? |
| Drug Approval | 1 | 2020 | 1325 | 0.03 | Why? |
| Medication Adherence | 1 | 2019 | 1270 | 0.02 | Why? |
| Influenza A virus | 1 | 2021 | 2234 | 0.02 | Why? |
| Microbial Sensitivity Tests | 1 | 2018 | 2886 | 0.02 | Why? |
| Blood Transfusion | 1 | 2018 | 1399 | 0.02 | Why? |
| Acute Disease | 1 | 2021 | 6029 | 0.02 | Why? |
| Patient Education as Topic | 1 | 2018 | 1476 | 0.02 | Why? |
| Antimalarials | 1 | 2020 | 2505 | 0.02 | Why? |
| Arrhythmias, Cardiac | 1 | 2021 | 2510 | 0.02 | Why? |
| Adult | 6 | 2021 | 244371 | 0.02 | Why? |
| Public Health Surveillance | 1 | 2021 | 3129 | 0.02 | Why? |
| Incidence | 2 | 2021 | 25622 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2018 | 5440 | 0.02 | Why? |
| Critical Illness | 2 | 2021 | 17281 | 0.02 | Why? |
| Sleep Wake Disorders | 1 | 2018 | 1463 | 0.02 | Why? |
| Patient Selection | 1 | 2020 | 4560 | 0.02 | Why? |
| Cause of Death | 1 | 2018 | 4823 | 0.02 | Why? |
| Quality Improvement | 1 | 2017 | 2435 | 0.02 | Why? |
| Survival Rate | 1 | 2018 | 9206 | 0.02 | Why? |
| Electronic Health Records | 1 | 2017 | 3492 | 0.02 | Why? |
| Research Design | 1 | 2020 | 5830 | 0.02 | Why? |
| Patient Safety | 1 | 2018 | 4885 | 0.02 | Why? |
| Disease Management | 1 | 2021 | 6841 | 0.02 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.01 | Why? |
| Internet | 1 | 2020 | 6204 | 0.01 | Why? |
| Disease Progression | 1 | 2021 | 13580 | 0.01 | Why? |
| Occupational Exposure | 1 | 2020 | 4742 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2020 | 7330 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2020 | 11041 | 0.01 | Why? |
| Attitude of Health Personnel | 1 | 2018 | 4741 | 0.01 | Why? |
| Pregnancy | 1 | 2021 | 23879 | 0.01 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.01 | Why? |
| Hospitals | 1 | 2017 | 11793 | 0.01 | Why? |
| Pneumonia | 1 | 2017 | 5652 | 0.01 | Why? |
| Prospective Studies | 1 | 2020 | 43301 | 0.01 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 8811 | 0.01 | Why? |
| Intensive Care Units | 1 | 2021 | 29594 | 0.01 | Why? |
| Emergency Service, Hospital | 1 | 2018 | 14232 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2020 | 53120 | 0.01 | Why? |
| United States | 1 | 2020 | 46150 | 0.01 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.01 | Why? |
| Adolescent | 1 | 2021 | 86841 | 0.01 | Why? |
| Young Adult | 1 | 2021 | 93724 | 0.01 | Why? |